Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in perioperative therapy for large pituitary neuroendocrine tumors
NCT06679816Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in adrenal insufficiency (AI), sponsored by Beijing Tiantan Hospital. Started Dec 2024; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT06679816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679816.